Applications for the respective renewals of the approval of the active substances acequinocyl, emamectin, orange oil, quinmerac, sodium silver thiosulfate, tembotrione and zinc phosphide were submitted and are being evaluated in accordance with Commission Implementing Regulation (EU) 2020/1740 [Commission Implementing Regulation (EU) 2020/1740 of 20 November 2020 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and repealing Commission Implementing Regulation (EU) No 844/2012 (OJ L 392, 23.11.2020, p. 20, ELI: http://data.europa.eu/eli/reg_impl/2020/1740/oj).].
Recital 41, Regulation (EU) 2026/2348
In force